About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 129629, 8 pages
http://dx.doi.org/10.1155/2013/129629
Research Article

Effect of Mesenchymal Stem Cells and a Novel Curcumin Derivative on Notch1 Signaling in Hepatoma Cell Line

1Unit of Biochemistry and Molecular Biology (UBMB), Department of Medical Biochemistry, Faculty of Medicine, Cairo University, Cairo 11956, Egypt
2Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo 11956, Egypt
3Department of Pathology, Faculty of Medicine, Cairo University, Cairo 11956, Egypt

Received 13 May 2013; Accepted 10 July 2013

Academic Editor: Akira Matsuno

Copyright © 2013 Mohamed Talaat Abdel Aziz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Jain, S. Singhal, P. Lee, and R. Xu, “Molecular genetics of hepatocellular neoplasia,” American Journal of Translational Research, vol. 2, no. 1, pp. 105–118, 2010. View at Scopus
  2. A. S. Ibrahim, I. A. Seifeldin, K. Ismail, A. Hablas, H. Hussein, and H. Elhamzawy, “Cancer in Egypt, Gharbiah,” Triennial Report of 2000–2002, Gharbiah Population-Based Cancer Registry, Middle East Cancer Consortium, Cairo, Egypt, 2007.
  3. L. S. Freedman, B. K. Edwards, L. A. G. Ries, and J. L. Young, “Cancer incidence in four member countries of the middle east cancer consortium (MECC) Compared with US SEER,” Tech. Rep. NIH Pub. no. 06-5873, National Cancer Institute, Bethesda, Md, USA, 2006.
  4. M. C. Yu, J.-M. Yuan, and S. C. Lu, “Alcohol, cofactors and the genetics of hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 23, no. 1, pp. S92–S97, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Marra, I. M. Sordelli, A. Lombardi et al., “Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview,” Journal of Translational Medicine, vol. 9, no. 1, article 171, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Yin, O. C. Velazquez, and Z.-J. Liu, “Notch signaling: emerging molecular targets for cancer therapy,” Biochemical Pharmacology, vol. 80, no. 5, pp. 690–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Wang, Y. Zhang, Y. Li, S. Banerjee, J. Liao, and F. H. Sarkar, “Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells,” Molecular Cancer Therapeutics, vol. 5, no. 3, pp. 483–493, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. B. J. Collins, W. Kleeberger, and D. W. Ball, “Notch in lung development and lung cancer,” Seminars in Cancer Biology, vol. 14, no. 5, pp. 357–364, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Ning, L. Wentworth, H. Chen, and S. M. Weber, “Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma,” American Journal of Translational Research, vol. 1, no. 4, pp. 358–366, 2009. View at Scopus
  10. A. Salamon and E. Toldy, “Adult bone marrow derived mesenchymal stem cells as stem cells for tissue repair,” Clinical and Experimental Medical Journal, vol. 3, no. 3, pp. 369–379, 2009. View at Publisher · View at Google Scholar
  11. G. J. M. Maestroni, E. Hertens, and P. Galli, “Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice,” Cellular and Molecular Life Sciences, vol. 55, no. 4, pp. 663–667, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Nakamura, Y. Ito, Y. Kawano et al., “Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model,” Gene Therapy, vol. 11, no. 14, pp. 1155–1164, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Pisati, M. Belicchi, F. Acerbi et al., “Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models,” Cancer Research, vol. 67, no. 7, pp. 3054–3063, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Liao, J. Xia, Z. Chen et al., “Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of notch-1 and NF-κB signaling pathways,” Journal of Cellular Biochemistry, vol. 112, no. 4, pp. 1055–1065, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Subramaniam, S. Ponnurangam, P. Ramamoorthy et al., “Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling,” PLoS One, vol. 7, no. 2, Article ID e30590, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Rezq, M. T. Abdel Aziz, and T. A. Kumosani, “Long acting conserved natural functional groups curcumin,” EP 2365956 A2, 2011.
  17. B. Johnstone, T. M. Hering, A. I. Caplan, V. M. Goldberg, and J. U. Yoo, “In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells,” Experimental Cell Research, vol. 238, no. 1, pp. 265–272, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Kadiyala, R. G. Young, M. A. Thiede, and S. P. Bruder, “Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro,” Cell Transplantation, vol. 6, no. 2, pp. 125–134, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Jaiswal, S. Haynesworth, A. Caplan, and S. P. Bruder, “Osteogenic differentiation of purified, culture- expanded human mesenchymal stem cells in vitro,” Journal of Cellular Biochemistry, vol. 64, pp. 295–312, 1997.
  20. L. Hou, H. Cao, D. Wang et al., “Induction of umbilical cord blood mesenchymal stem cells into neuron-like cells in vitro,” International Journal of Hematology, vol. 78, no. 3, pp. 256–261, 2003. View at Scopus
  21. K. Yamazoe, H. Mishima, K. Torigoe et al., “Effects of atelocollagen gel containing bone marrow-derived stromal cells on repair of osteochondral defect in a dog,” Journal of Veterinary Medical Science, vol. 69, no. 8, pp. 835–839, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Villanueva, P. Newell, D. Y. Chiang, S. L. Friedman, and J. M. Llovet, “Genomics and signaling pathways in hepatocellular carcinoma,” Seminars in Liver Disease, vol. 27, no. 1, pp. 55–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Llovet, A. M. Di Bisceglie, J. Bruix et al., “Design and endpoints of clinical trials in hepatocellular carcinoma,” Journal of the National Cancer Institute, vol. 100, no. 10, pp. 698–711, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Androutsellis-Theotokis, R. R. Leker, F. Soldner et al., “Notch signalling regulates stem cell numbers in vitro and in vivo,” Nature, vol. 442, no. 7104, pp. 823–826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Miele, H. Miao, and B. J. Nickoloff, “NOTCH signaling as a novel cancer therapeutic target,” Current Cancer Drug Targets, vol. 6, no. 4, pp. 313–323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. F. MacKenzie, P. Duriez, F. Wong, M. Noseda, and A. Karsan, “Notch4 Inhibits endothelial apoptosis via RBP-Jκ-dependent and -independent Pathways,” Journal of Biological Chemistry, vol. 279, no. 12, pp. 11657–11663, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Nair, K. Somasundaram, and S. Krishna, “Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway,” Journal of Virology, vol. 77, no. 12, pp. 7106–7112, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Oswald, S. Liptay, G. Adler, and R. M. Schmid, “NF-κB2 is a putative target gene of activated Notch-1 via RBP-Jκ,” Molecular and Cellular Biology, vol. 18, no. 4, pp. 2077–2088, 1998. View at Scopus
  29. B. J. Nickoloff, J.-Z. Qin, V. Chaturvedi, M. F. Denning, B. Bonish, and L. Miele, “Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-κB and PPARγ,” Cell Death and Differentiation, vol. 9, no. 8, pp. 842–855, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Bash, W.-X. Zong, S. Banga et al., “Rel/NF-κB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors,” EMBO Journal, vol. 18, no. 10, pp. 2803–2811, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Ronchini and A. J. Capobianco, “Induction of cyclin D1 transcription and CDK2 activity by Notchic: implication for cell cycle disruption in transformation by Notchic,” Molecular and Cellular Biology, vol. 21, no. 17, pp. 5925–5934, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Murata, M. Hattori, N. Hirai et al., “Hes1 directly controls cell proliferation through the transcriptional repression of p27Kip1,” Molecular and Cellular Biology, vol. 25, no. 10, pp. 4262–4271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Levicar, I. Dimarakis, C. Flores, J. Tracey, M. Y. Gordon, and N. A. Habib, “Stem cells as a treatment for chronic liver disease and diabetes,” Handbook of experimental pharmacology, no. 180, pp. 243–262, 2007. View at Scopus
  34. S. Liao, J. Xia, Z. Chen et al., “Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of notch-1 and NF-κB signaling pathways,” Journal of Cellular Biochemistry, vol. 112, no. 4, pp. 1055–1065, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Ohashi, Y. Tsuchiya, K. Koizumi, H. Sakurai, and I. Saiki, “Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model,” Oncology, vol. 65, no. 3, pp. 250–258, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. S.-X. Cui, X.-J. Qu, Y.-Y. Xie et al., “Curcumin inhibits telomerase activity in human cancer cell lines,” International Journal of Molecular Medicine, vol. 18, no. 2, pp. 227–231, 2006. View at Scopus
  37. L. Jia, H. Wang, S. Qu, X. Miao, and J. Zhang, “CD147 regulates vascular endothelial growth factor—a expression, tumorigenicity, and chemosensitivity to curcumin in hepatocellular carcinoma,” IUBMB Life, vol. 60, no. 1, pp. 57–63, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Wang, Y. Zhang, Y. Li, S. Banerjee, J. Liao, and F. H. Sarkar, “Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells,” Molecular Cancer Therapeutics, vol. 5, no. 3, pp. 483–493, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. M. C. Cantarini, S. M. De La Monte, M. Pang et al., “Aspartyl-asparagyl β hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and Notch signaling mechanisms,” Hepatology, vol. 44, no. 2, pp. 446–457, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Gao, Z. Song, Y. Chen et al., “Deregulated expression of Notch receptors in human hepatocellular carcinoma,” Digestive and Liver Disease, vol. 40, no. 2, pp. 114–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Qi, H. An, Y. Yu et al., “Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis,” Cancer Research, vol. 63, no. 23, pp. 8323–8329, 2003. View at Scopus
  42. J. P. Alao, “The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention,” Molecular Cancer, vol. 6, article 24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. S. S. Thorgeirsson and J. W. Grisham, “Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence,” Hepatology, vol. 43, no. 1, pp. 2–8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. Y.-Y. Jang, M. I. Collector, S. B. Baylin, A. M. Diehl, and S. J. Sharkis, “Hematopoietic stem cells convert into liver cells within days without fusion,” Nature Cell Biology, vol. 6, no. 6, pp. 532–539, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Y. Khakoo, S. Pati, S. A. Anderson et al., “Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma,” Journal of Experimental Medicine, vol. 203, no. 5, pp. 1235–1247, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. J. M. Aliotta, F. M. Sanchez-Guijo, G. J. Dooner et al., “Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation,” Stem Cells, vol. 25, no. 9, pp. 2245–2256, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. B. Parekkadan, D. Van Poll, K. Suganuma et al., “Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure,” PLoS One, vol. 2, no. 9, article e941, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Qiao, Z. Xu, T. Zhao et al., “Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model,” Cell Research, vol. 18, no. 4, pp. 500–507, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Yao, L. Duan, M. Fan, and X. Wu, “γ-secretase inhibitors exerts antitumor activity via down-regulation of Notch and Nuclear factor kappa B in human tongue carcinoma cells,” Oral Diseases, vol. 13, no. 6, pp. 555–563, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Buhrmann, A. Mobasheri, U. Matis, and M. Shakibaei, “Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment,” Arthritis Research and Therapy, vol. 12, article R127, no. 4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Friedman, “Stem cells with curcumin reportedly help heal spinal cord,” Neurology Today, vol. 10, no. 24, p. P20, 2010.
  52. B. B. Aggarwal, S. Banerjee, U. Bharadwaj, B. Sung, S. Shishodia, and G. Sethi, “Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines,” Biochemical Pharmacology, vol. 73, no. 7, pp. 1024–1032, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. M. T. Abdel Aziz, H. H. Fouad, N. K. Roshdy et al., “Effect of human mesenchymal stem cells onhepatoma cell line,” Stem Cell Studies, vol. 1, article e12, 2011.